Advances and challenges in gene therapies (part 1)

Tuesday, September 13, 2022
PLENARY
13-PM-PLENARY 3:00 PM > 4:00 PM Advances and challenges in gene therapies (part 1) Apollon Auditorium

3:00 PM S6L1 Challenges of AAV Gene Therapy Development for Duchenne Muscular Dystrophy > F. Francesco MUNTONI (London, Uk) 3:20 PM S6L2 The management of safety of gene therapy of neuromuscular diseases, an emblematic example > S. Serge BRAUN (Evry, France) 3:40 PM S6L3 The liver as a model tissue to develop innovative solutions to the existing limitations of AAV gene therapy > G. Giuseppe RONZITTI (Evry, France)

Copyright © key4events - All rights reserved